| Year |
Citation |
Score |
| 2021 |
Olmeda D, Cerezo-Wallis D, Mucientes C, Calvo TG, Cañón E, Alonso-Curbelo D, Ibarz N, Muñoz J, Rodriguez-Peralto JL, Ortiz-Romero P, Ortega S, Soengas MS. Live imaging of neolymphangiogenesis identifies acute antimetastatic roles of dsRNA mimics. Embo Molecular Medicine. e12924. PMID 34762341 DOI: 10.15252/emmm.202012924 |
0.313 |
|
| 2020 |
Lund AW, Soengas MS. Lymph: (Fe)rrying Melanoma to Safety. Cancer Cell. PMID 32916127 DOI: 10.1016/J.Ccell.2020.08.011 |
0.329 |
|
| 2019 |
Bagati A, Moparthy S, Fink EE, Bianchi-Smiraglia A, Yun DH, Kolesnikova M, Udartseva OO, Wolff DW, Roll MV, Lipchick BC, Han Z, Kozlova NI, Jowdy P, Berman AE, Box NF, ... ... Soengas MS, et al. KLF9-dependent ROS regulate melanoma progression in stage-specific manner. Oncogene. PMID 30664687 DOI: 10.1038/S41388-019-0689-6 |
0.466 |
|
| 2019 |
Karras P, Riveiro-Falkenbach E, Cañón E, Tejedo C, Calvo TG, Martínez-Herranz R, Alonso-Curbelo D, Cifdaloz M, Perez-Guijarro E, Gómez-López G, Ximenez-Embun P, Muñoz J, Megias D, Olmeda D, Moscat J, ... ... Soengas MS, et al. p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors. Cancer Cell. 35: 46-63.e10. PMID 30581152 DOI: 10.1016/J.Ccell.2018.11.008 |
0.394 |
|
| 2017 |
Cifdaloz M, Osterloh L, Graña O, Riveiro-Falkenbach E, Ximénez-Embún P, Muñoz J, Tejedo C, Calvo TG, Karras P, Olmeda D, Miñana B, Gómez-López G, Cañon E, Eyras E, Guo H, ... ... Soengas MS, et al. Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1. Nature Communications. 8: 2249. PMID 29269732 DOI: 10.1038/S41467-017-02353-Y |
0.396 |
|
| 2017 |
Soengas MS, Patton EE. Location, Location, Location: Spatio-Temporal Cues That Define the Cell of Origin in Melanoma. Cell Stem Cell. 21: 559-561. PMID 29100006 DOI: 10.1016/J.Stem.2017.10.009 |
0.32 |
|
| 2017 |
Ndoye A, Budina-Kolomets A, Kugel CH, Webster MR, Kaur A, Behera R, Rebecca VW, Li L, Brafford PA, Liu Q, Vashisht Gopal YN, Davies MA, Mills GB, Xu X, Wu H, ... ... Soengas MS, et al. ATG5 mediates a positive feedback loop between Wnt signaling and autophagy in melanoma. Cancer Research. PMID 28887323 DOI: 10.1158/0008-5472.Can-17-0907 |
0.432 |
|
| 2017 |
Olmeda D, Cerezo-Wallis D, Riveiro-Falkenbach E, Pennacchi PC, Contreras-Alcalde M, Ibarz N, Cifdaloz M, Catena X, Calvo TG, Cañón E, Alonso-Curbelo D, Suarez J, Osterloh L, Graña O, Mulero F, ... ... Soengas MS, et al. Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine. Nature. 546: 676-680. PMID 28658220 DOI: 10.1038/Nature22977 |
0.39 |
|
| 2016 |
Wurth L, Papasaikas P, Olmeda D, Bley N, Calvo GT, Guerrero S, Cerezo-Wallis D, Martinez-Useros J, García-Fernández M, Hüttelmaier S, Soengas MS, Gebauer F. UNR/CSDE1 Drives a Post-transcriptional Program to Promote Melanoma Invasion and Metastasis. Cancer Cell. 30: 694-707. PMID 27908735 DOI: 10.1016/J.Ccell.2016.10.004 |
0.357 |
|
| 2016 |
Riveiro-Falkenbach E, Ruano Y, García-Martín RM, Lora D, Cifdaloz M, Acquadro F, Ballestin C, Ortiz-Romero PL, Soengas MS, Rodríguez-Peralto JL. DEK oncogene is overexpressed during melanoma progression. Pigment Cell & Melanoma Research. PMID 27893188 DOI: 10.1111/Pcmr.12563 |
0.447 |
|
| 2016 |
Pérez-Guijarro E, Karras P, Cifdaloz M, Martínez-Herranz R, Cañón E, Graña O, Horcajada-Reales C, Alonso-Curbelo D, Calvo TG, Gómez-López G, Bellora N, Riveiro-Falkenbach E, Ortiz-Romero PL, Rodríguez-Peralto JL, Maestre L, ... ... Soengas MS, et al. Lineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers. Nature Communications. 7: 13418. PMID 27857118 DOI: 10.1038/Ncomms13418 |
0.418 |
|
| 2016 |
Cerezo-Wallis D, Soengas MS. Understanding Tumor-Antigen Presentation in the New Era of Cancer Immunotherapy. Current Pharmaceutical Design. 22: 6234-6250. PMID 27568731 DOI: 10.2174/1381612822666160826111041 |
0.33 |
|
| 2016 |
García-Fernández M, Karras P, Checinska A, Cañón E, Calvo GT, Gómez-López G, Cifdaloz M, Colmenar A, Espinosa-Hevia L, Olmeda D, Soengas MS. Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5. Autophagy. 1-15. PMID 27464255 DOI: 10.1080/15548627.2016.1199301 |
0.434 |
|
| 2016 |
Merlino G, Herlyn M, Fisher DE, Bastian BC, Flaherty KT, Davies MA, Wargo JA, Curiel-Lewandrowski C, Weber MJ, Leachman SA, Soengas MS, McMahon M, Harbour JW, Swetter SM, Aplin AE, et al. The state of melanoma: challenges and opportunities. Pigment Cell & Melanoma Research. PMID 27087480 DOI: 10.1111/Pcmr.12475 |
0.307 |
|
| 2016 |
Maes H, Olmeda D, Soengas MS, Agostinis P. Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies. The Febs Journal. 283: 25-38. PMID 26443003 DOI: 10.1111/Febs.13545 |
0.349 |
|
| 2015 |
Alonso-Curbelo D, Osterloh L, Cañón E, Calvo TG, Martínez-Herranz R, Karras P, Martínez S, Riveiro-Falkenbach E, Romero PO, Rodríguez-Peralto JL, Pastor J, Soengas MS. RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma development. Oncotarget. 6: 11848-62. PMID 26008978 DOI: 10.18632/Oncotarget.4055 |
0.44 |
|
| 2015 |
Alonso-Curbelo D, Soengas MS. Hyperactivated endolysosomal trafficking in melanoma. Oncotarget. 6: 2583-4. PMID 25682879 DOI: 10.18632/Oncotarget.3141 |
0.37 |
|
| 2014 |
Alonso-Curbelo D, Riveiro-Falkenbach E, Pérez-Guijarro E, Cifdaloz M, Karras P, Osterloh L, Megías D, Cañón E, Calvo TG, Olmeda D, Gómez-López G, Graña O, Sánchez-Arévalo Lobo VJ, Pisano DG, Wang HW, ... ... Soengas MS, et al. RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway. Cancer Cell. 26: 61-76. PMID 24981740 DOI: 10.1016/J.Ccr.2014.04.030 |
0.465 |
|
| 2012 |
Soengas MS. Mitophagy or how to control the Jekyll and Hyde embedded in mitochondrial metabolism: implications for melanoma progression and drug resistance. Pigment Cell & Melanoma Research. 25: 721-31. PMID 22974269 DOI: 10.1111/Pcmr.12021 |
0.451 |
|
| 2012 |
Brohem CA, Massaro RR, Tiago M, Marinho CE, Jasiulionis MG, de Almeida RL, Rivelli DP, Albuquerque RC, de Oliveira TF, de Melo Loureiro AP, Okada S, Soengas MS, de Moraes Barros SB, Maria-Engler SS. Proteasome inhibition and ROS generation by 4-nerolidylcatechol induces melanoma cell death. Pigment Cell & Melanoma Research. 25: 354-69. PMID 22372875 DOI: 10.1111/J.1755-148X.2012.00992.X |
0.523 |
|
| 2012 |
Mannava S, Omilian AR, Wawrzyniak JA, Fink EE, Zhuang D, Miecznikowski JC, Marshall JR, Soengas MS, Sears RC, Morrison CD, Nikiforov MA. PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells. Oncogene. 31: 1484-92. PMID 21822300 DOI: 10.1038/Onc.2011.339 |
0.458 |
|
| 2012 |
Verhaegen M, Checinska A, Riblett MB, Wang S, Soengas MS. E2F1-dependent oncogenic addiction of melanoma cells to MDM2 Oncogene. 31: 828-841. PMID 21743494 DOI: 10.1038/Onc.2011.277 |
0.49 |
|
| 2011 |
Checinska A, Soengas MS. The gluttonous side of malignant melanoma: basic and clinical implications of macroautophagy. Pigment Cell & Melanoma Research. 24: 1116-32. PMID 21995431 DOI: 10.1111/J.1755-148X.2011.00927.X |
0.463 |
|
| 2010 |
Riveiro-Falkenbach E, Soengas MS. Control of tumorigenesis and chemoresistance by the DEK oncogene. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 2932-8. PMID 20501624 DOI: 10.1158/1078-0432.Ccr-09-2330 |
0.409 |
|
| 2010 |
Alonso-Curbelo D, Soengas MS. Self-killing of melanoma cells by cytosolic delivery of dsRNA: wiring innate immunity for a coordinated mobilization of endosomes, autophagosomes and the apoptotic machinery in tumor cells. Autophagy. 6: 148-50. PMID 19923903 DOI: 10.4161/Auto.6.1.10464 |
0.452 |
|
| 2009 |
Khodadoust MS, Verhaegen M, Kappes F, Riveiro-Falkenbach E, Cigudosa JC, Kim DS, Chinnaiyan AM, Markovitz DM, Soengas MS. Melanoma proliferation and chemoresistance controlled by the DEK oncogene. Cancer Research. 69: 6405-13. PMID 19679545 DOI: 10.1158/0008-5472.Can-09-1063 |
0.512 |
|
| 2009 |
Tormo D, Checińska A, Alonso-Curbelo D, Pérez-Guijarro E, Cañón E, Riveiro-Falkenbach E, Calvo TG, Larribere L, Megías D, Mulero F, Piris MA, Dash R, Barral PM, Rodríguez-Peralto JL, Ortiz-Romero P, ... ... Soengas MS, et al. Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells. Cancer Cell. 16: 103-14. PMID 19647221 DOI: 10.1016/J.Ccr.2009.07.004 |
0.433 |
|
| 2009 |
Jia L, Soengas MS, Sun Y. ROC1/RBX1 E3 ubiquitin ligase silencing suppresses tumor cell growth via sequential induction of G2-M arrest, apoptosis, and senescence. Cancer Research. 69: 4974-82. PMID 19509229 DOI: 10.1158/0008-5472.Can-08-4671 |
0.434 |
|
| 2009 |
VanBrocklin MW, Verhaegen M, Soengas MS, Holmen SL. Mitogen-activated protein kinase inhibition induces translocation of Bmf to promote apoptosis in melanoma. Cancer Research. 69: 1985-94. PMID 19244105 DOI: 10.1158/0008-5472.Can-08-3934 |
0.497 |
|
| 2008 |
Soengas MS. Looping tumor suppression. Pigment Cell & Melanoma Research. 21: 592-3. PMID 18801010 DOI: 10.1111/J.1755-148X.2008.00502.X |
0.301 |
|
| 2008 |
Zhuang D, Mannava S, Grachtchouk V, Tang WH, Patil S, Wawrzyniak JA, Berman AE, Giordano TJ, Prochownik EV, Soengas MS, Nikiforov MA. C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. Oncogene. 27: 6623-34. PMID 18679422 DOI: 10.1038/Onc.2008.258 |
0.456 |
|
| 2008 |
Soengas MS. Cancer: Ins and outs of tumour control. Nature. 454: 586-7. PMID 18668094 DOI: 10.1038/454586A |
0.341 |
|
| 2008 |
Sikora MJ, Bauer JA, Verhaegen M, Belbin TJ, Prystowsky MB, Taylor JC, Brenner JC, Wang S, Soengas MS, Bradford CR, Carey TE. Anti-oxidant treatment enhances anti-tumor cytotoxicity of (-)-gossypol. Cancer Biology & Therapy. 7: 767-76. PMID 18376141 DOI: 10.4161/Cbt.7.5.5767 |
0.464 |
|
| 2008 |
Konopleva M, Tsao T, Ling X, Kojima K, Watt J, Mak DH, Verhaegen M, Bornmann W, Soengas M, Andreeff M. Activation of p53 Signaling Is Synergistically Enhanced by Bcl-2 Inhibition through Induction of Noxa and Bak/Bax Heterodimers Resulting in Apoptosis of AML Stem Cells Blood. 112: 2940-2940. DOI: 10.1182/Blood.V112.11.2940.2940 |
0.426 |
|
| 2007 |
Nikiforov MA, Riblett M, Tang WH, Gratchouck V, Zhuang D, Fernandez Y, Verhaegen M, Varambally S, Chinnaiyan AM, Jakubowiak AJ, Soengas MS. Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. Proceedings of the National Academy of Sciences of the United States of America. 104: 19488-93. PMID 18042711 DOI: 10.1073/Pnas.0708380104 |
0.455 |
|
| 2007 |
Kaneko T, Zhang Z, Mantellini MG, Karl E, Zeitlin B, Verhaegen M, Soengas MS, Lingen M, Strieter RM, Nunez G, Nör JE. Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth. Cancer Research. 67: 9685-93. PMID 17942898 DOI: 10.1158/0008-5472.Can-07-1497 |
0.425 |
|
| 2007 |
Wang H, Mannava S, Grachtchouk V, Zhuang D, Soengas MS, Gudkov AV, Prochownik EV, Nikiforov MA. c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle. Oncogene. 27: 1905-15. PMID 17906696 DOI: 10.1038/Sj.Onc.1210823 |
0.432 |
|
| 2007 |
Karl E, Zhang Z, Dong Z, Neiva KG, Soengas MS, Koch AE, Polverini PJ, Núñez G, Nör JE. Unidirectional crosstalk between Bcl-xL and Bcl-2 enhances the angiogenic phenotype of endothelial cells. Cell Death and Differentiation. 14: 1657-66. PMID 17572663 DOI: 10.1038/Sj.Cdd.4402174 |
0.374 |
|
| 2007 |
Wolter KG, Verhaegen M, Fernández Y, Nikolovska-Coleska Z, Riblett M, de la Vega CM, Wang S, Soengas MS. Therapeutic window for melanoma treatment provided by selective effects of the proteasome on Bcl-2 proteins. Cell Death and Differentiation. 14: 1605-16. PMID 17541428 DOI: 10.1038/Sj.Cdd.4402163 |
0.732 |
|
| 2007 |
Smalley KS, Contractor R, Haass NK, Kulp AN, Atilla-Gokcumen GE, Williams DS, Bregman H, Flaherty KT, Soengas MS, Meggers E, Herlyn M. An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells. Cancer Research. 67: 209-17. PMID 17210701 DOI: 10.1158/0008-5472.Can-06-1538 |
0.493 |
|
| 2006 |
Verhaegen M, Bauer JA, MartÃn de la Vega C, Wang G, Wolter KG, Brenner JC, Nikolovska-Coleska Z, Bengtson A, Nair R, Elder JT, Van Brocklin M, Carey TE, Bradford CR, Wang S, Soengas MS. A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species. Cancer Research. 66: 11348-59. PMID 17145881 DOI: 10.1158/0008-5472.Can-06-1748 |
0.756 |
|
| 2006 |
Konopleva M, Contractor R, Tsao T, Samudio I, Ruvolo PP, Kitada S, Deng X, Zhai D, Shi YX, Sneed T, Verhaegen M, Soengas M, Ruvolo VR, McQueen T, Schober WD, et al. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell. 10: 375-88. PMID 17097560 DOI: 10.1016/J.Ccr.2006.10.006 |
0.463 |
|
| 2006 |
Denoyelle C, Abou-Rjaily G, Bezrookove V, Verhaegen M, Johnson TM, Fullen DR, Pointer JN, Gruber SB, Su LD, Nikiforov MA, Kaufman RJ, Bastian BC, Soengas MS. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nature Cell Biology. 8: 1053-63. PMID 16964246 DOI: 10.1038/Ncb1471 |
0.4 |
|
| 2006 |
Fribley AM, Evenchik B, Zeng Q, Park BK, Guan JY, Zhang H, Hale TJ, Soengas MS, Kaufman RJ, Wang CY. Proteasome inhibitor PS-341 induces apoptosis in cisplatin-resistant squamous cell carcinoma cells by induction of Noxa. The Journal of Biological Chemistry. 281: 31440-7. PMID 16928686 DOI: 10.1074/Jbc.M604356200 |
0.452 |
|
| 2006 |
Poynter JN, Elder JT, Fullen DR, Nair RP, Soengas MS, Johnson TM, Redman B, Thomas NE, Gruber SB. BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Research. 16: 267-73. PMID 16845322 DOI: 10.1097/01.Cmr.0000222600.73179.F3 |
0.304 |
|
| 2006 |
Tuve S, Racek T, Niemetz A, Schultz J, Soengas MS, Pützer BM. Adenovirus-mediated TA-p73β gene transfer increases chemosensitivity of human malignant melanomas Apoptosis. 11: 235-243. PMID 16502261 DOI: 10.1007/S10495-006-3407-0 |
0.48 |
|
| 2006 |
Fernández Y, Miller TP, Denoyelle C, Esteban JA, Tang WH, Bengston AL, Soengas MS. Chemical blockage of the proteasome inhibitory function of bortezomib: impact on tumor cell death. The Journal of Biological Chemistry. 281: 1107-18. PMID 16278210 DOI: 10.1074/Jbc.M511607200 |
0.45 |
|
| 2006 |
Soengas MS, Gerald WL, Cordon-Cardo C, Lazebnik Y, Lowe SW. Apaf-1 expression in malignant melanoma. Cell Death and Differentiation. 13: 352-3. PMID 16110320 DOI: 10.1038/Sj.Cdd.4401755 |
0.34 |
|
| 2006 |
Verhaegen M, Bauer J, Wang G, Wolter K, Brenner C, Nikolovska-Coleska Z, Carey T, Wang S, Soengas M. A novel BH3 mimetic reveals a MAPK-dependent mechanism of melanoma cell survival controlled by p53 and reactive oxygen species Melanoma Research. 16. DOI: 10.1097/00008390-200609001-00015 |
0.721 |
|
| 2006 |
Denoyelle C, Wolter K, Abou-Rjaily G, Kaufman R, Soengas M. New role of the endoplasmic reticulum in the control of melanocyte transformation Melanoma Research. 16: S4. DOI: 10.1097/00008390-200609001-00004 |
0.678 |
|
| 2006 |
Tuve S, Racek T, Niemetz A, Schultz J, Soengas MS, Pützer BM. 939. Adenovirus-Mediated TA-p73β Gene Transfer Leads to Chemosensitization of Human Malignant Melanoma Molecular Therapy. 13. DOI: 10.1016/J.Ymthe.2006.08.1030 |
0.408 |
|
| 2005 |
Michaloglou C, Vredeveld LCW, Soengas MS, Denoyelle C, Kuilman T, Van Der Horst CMAM, Majoor DM, Shay JW, Mooi WJ, Peeper DS. BRAFE600-associated senescence-like cell cycle arrest of human naevi Nature. 436: 720-724. PMID 16079850 DOI: 10.1038/Nature03890 |
0.433 |
|
| 2005 |
Fernández Y, Verhaegen M, Miller TP, Rush JL, Steiner P, Opipari AW, Lowe SW, Soengas MS. Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Research. 65: 6294-304. PMID 16024631 DOI: 10.1158/0008-5472.Can-05-0686 |
0.534 |
|
| 2003 |
Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene. 22: 3138-51. PMID 12789290 DOI: 10.1038/Sj.Onc.1206454 |
0.477 |
|
| 2003 |
Hostanska K, Vuong V, Rocha S, Soengas MS, Glanzmann C, Saller R, Bodis S, Pruschy M. Recombinant mistletoe lectin induces p53-independent apoptosis in tumour cells and cooperates with ionising radiation. British Journal of Cancer. 88: 1785-92. PMID 12771996 DOI: 10.1038/Sj.Bjc.6600982 |
0.401 |
|
| 2001 |
Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordón-Cardó C, Lowe SW. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature. 409: 207-11. PMID 11196646 DOI: 10.1038/35051606 |
0.48 |
|
| 2001 |
Soengas MS, Lowe SW. p53 and p73: seeing double? Nature Genetics. 26: 391-2. PMID 11101828 DOI: 10.1038/82497 |
0.364 |
|
| 1999 |
Soengas MS, Alarcón RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW, Lowe SW. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science (New York, N.Y.). 284: 156-9. PMID 10102818 DOI: 10.1126/Science.284.5411.156 |
0.468 |
|
| 1998 |
Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM, et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell. 94: 339-52. PMID 9708736 DOI: 10.1016/S0092-8674(00)81477-4 |
0.401 |
|
| 1998 |
Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, Kägi D, Hakem A, McCurrach M, Khoo W, Kaufman SA, Senaldi G, Howard T, Lowe SW, Mak TW. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes & Development. 12: 806-19. PMID 9512515 DOI: 10.1101/Gad.12.6.806 |
0.406 |
|
| Show low-probability matches. |